It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Heterogeneity of cell phenotypes remains a barrier in progressing cell research and a challenge in conquering cancer-related drug resistance. Cell morphology, the most direct property of cell phenotype, evolves along the progression of the cell cycle; meanwhile, cell motility, the dynamic property of cell phenotype, also alters over the cell cycle. However, a quantifiable research understanding the relationship between the cell cycle and cell migration is missing. Herein, we coordinate the migratory behaviours of NIH 3T3 fibroblasts to their corresponding phases of the cell cycle, the G1, the S, and the G2 phases, and explain the relationship through the spatiotemporal arrangements between the Rho GTPases’ signals and cyclin-dependent kinase inhibitors, p21Cip1, and p27Kip1. Taken together, we demonstrate that both cell morphology and the dynamic subcellular behaviour are homogenous within each stage of the cell cycle phases but heterogenous between phases through quantitative cell analyses and an interactive molecular mechanism between the cell cycle and cell migration, posing potential implications in countering drug resistance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Shandong University of Traditional Chinese Medicine, Innovation Research Institute of Traditional Chinese Medicine, Jinan, China (GRID:grid.464402.0) (ISNI:0000 0000 9459 9325); University of Florida, Department of Chemical Engineering, Gainesville, USA (GRID:grid.15276.37) (ISNI:0000 0004 1936 8091)
2 Shandong University of Traditional Chinese Medicine, Innovation Research Institute of Traditional Chinese Medicine, Jinan, China (GRID:grid.464402.0) (ISNI:0000 0000 9459 9325)
3 University of Florida, Department of Chemical Engineering, Gainesville, USA (GRID:grid.15276.37) (ISNI:0000 0004 1936 8091)
4 University of Waterloo, Department of Statistics and Actuarial Science, Waterloo, Canada (GRID:grid.46078.3d) (ISNI:0000 0000 8644 1405)